Infiltrating breast carcinoma smaller than 0.5 Centimeters: Is lymph node dissection necessary?

Cancer

Volumn 85, Issue 10, 1999, Pages 2206-2211

  Saiz, Enma ^a   Toonkel, Rebecca ^a   Poppiti Jr , Robert J ^a   Robinson, Morton J ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Axillary lymph node dissection; Axillary metastases; Breast carcinoma; Laminin; Nuclear grade; Prognostic indicators; TNM staging; Type IV collagen

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INCIDENCE; CANCER INFILTRATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0033562476     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990515)85:10<2206::AID-CNCR15>3.0.CO;2-7     Document Type: Article

References (30)

1. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997;70:1918-22.
2. Bedwani R, Vana J, Rosner D, Schmitz RL, Murphy GP. Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons. Cancer 1981;47:2679-778.
3. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;218:338-49.
4. Carter CL, Allen C, Hensen DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
5. Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer: a multivariate analysis. Cancer 1994;73:350-3.
6. Fisher B, Slack NH, Bross IDJ, and cooperating investigators. Cancer of the breast: size of neoplasm and prognosis. Cancer 1969;24:1071-80.
7. Kambouris AA. Axillary node metastases in relation to size and location of breast cancers: analysis of 147 patients. Am Surg 1996;62-519-24.
8. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-24.
9. Pandelidis SM, Peters KL, Walusimbi MS, Casady RL, Laux SV, Cavanaugh SH, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997;184:397-8.
10. Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 1989;157:501-2.
11. Seidman JD, Schnaper LA, Aisner SC. Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastases. Cancer 1995;75:65-71.
12. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994;73:664-7.
13. Sinn HP, Oelmann A, Anton HW, Diel IJ. Metastatic potential of small and minimally invasive breast carcinomas. Virchows Arch 1994;425:237-41.
14. Stierer M, Rosen HR, Weber R, Marczell A, Kornek GV, Czerwenka E. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter. Surg Gynecol Obstet 1992;175:151-60.
15. Wong JH, Kopland KH, Morton DL. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 1990;125:1298-1302.
16. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-97.
17. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-8.
18. Hensen DE, Fielding P, Grignon DJ, Page DL, Hammond ME, Nash G, et al. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Arch Pathol Lab Med 1994;199:1109-12.
19. Berho M, Viciana AL, Poppiti RJ, Ruiz P. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance. J Fla Med Assoc 1997;84:104-10.
20. Pinder SE, Ellis IO, Galea M, O'Rourke S, Blarney RW, Elston CW. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994;24:41-7.
21. Watanabe N, Nakajima I, Abe S, Ogura S, Isobe H, Kawakami Y. Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung. J Clin Pathol 1994;47: 613-5.
22. Hewitt RE, Powe DG, Morrell K, Bailey E, Leach IH, Ellis IO, et al. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br J Cancer 1997;75:221-9.
23. Matsui K, Kitagawa M, Sugiyama S, Yamamoto K. Distribution pattern of basement membrane components is one of the significant prognostic correlates in peripheral lung adenocarcinomas. Hum Pathol 1995;26:186-94.
24. American Joint Committee on Cancer. Beahrs O, Henson D, Hutter R, Kennedy B, editors. Manual for staging of cancer. 4th edition. Philadelphia: J. B. Lippincott, 1992;149-54.
25. Elston C, Ellis I. Pathologic prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
26. Robbins P, Pinder S, de Klerk N, Dawklns H, Harvey J, Sterrett G, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 1995;26: 873-9.
27. Kirkwood B. Medical statistics. Oxford: Blackwell, 1988: 234,xii.
28. Snedecor G, Cochran W. Statistical Methods. Ames, Iowa: State University Press, 1980:507,xvi.
29. MacGrogan G, Jollet I, Huet S, Sierankowski G, Picot V, Bonichon F, et al. Comparison of quantitative and semi-quantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma. Mod Pathol 1997;10:769-76.
30. Mori M, Kohli A, Baker SP, Savas L, Fraire AE. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mod Pathol 1997; 10:572-7.